Is this you? Create Your Porfile
Avatar

Klaus Benke

Bayer Corporation

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Klaus Benke is active.

Explore More

Publication

Featured researches published by Klaus Benke.

Archive | 2005

Solid, modified-release pharmaceutical dosage forms which can be administered orally

Klaus Benke; Jan-Olav Henck

Archive | 2006

Pharmaceutical dosage form containing an active principle combination of nifedipine and/or nisoldipine and of an angiotensin ii antagonist

Andreas Ohm; Klaus Benke; Hanna Tinel; Joachim Hütter

Archive | 2004

Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung

Klaus Benke; Jan-Olav Henck

Archive | 2006

Pharmazeutische darreichungsformen enthaltend eine wirkstoffkombination von nifedipin und/oder nisoldipin und einem angiotensin-ii antagonisten

Andreas Ohm; Klaus Benke; Hanna Tinel; Joachim Hütter

Archive | 2006

Pharmaceutical dosage form based on an osmotic active ingredient release system comprising an active ingredient combination of nifedipine and/or nisoldipine and an angiotensin ii antagonist

Andreas Ohm; Klaus Benke; Hanna Tinel; Joachim Huetter

Archive | 2006

Forme dosifiee pharmaceutique contenant une association de principes actifs de nifedipine et/ou de nisoldipine et un antagoniste de l'angiotensine-ii

Andreas Ohm; Klaus Benke; Hanna Tinel; Joachim Huetter

Archive | 2005

Pharmazeutische Darreichungsformen enthaltend eine Wirkstoffkombination von Nifedipin und/oder Nisoldipin und einem Angiotensin-II Antagonisten Pharmaceutical dosage forms comprising an active ingredient combination of nifedipine and / or nisoldipine and an angiotensin II antagonist

Klaus Benke; Joachim Hütter; Andreas Ohm; Hanna Tinel

Archive | 2005

Produits pharmaceutiques solides, administres par voie orale et contenant du rivaroxaban, a liberation modifiee

Klaus Benke; Jan-Olav Henck

Archive | 2005

Solid, orally administrable pharmaceutical dosage forms containing rivaroxaban modified release

Klaus Benke; Jan-Olav Henck

Archive | 2005

Feste, oral applizierbare pharmazeutische darreichungsformen enthaltend rivaroxaban mit modifizierter freisetzung Solid, orally administered pharmaceutical dosage forms containing rivaroxaban with modified release

Klaus Benke; Jan-Olav Henck

Explore More

Collaboration

Dive into the Klaus Benke's collaboration.

Top Co-Authors
Avatar

Jan-Olav Henck

Bayer Corporation

View shared research outputs
Top Co-Authors
Avatar

Andreas Ohm

Bayer Corporation

View shared research outputs
Top Co-Authors
Avatar

Hanna Tinel

Bayer Corporation

View shared research outputs
Top Co-Authors
Avatar

Joachim Hütter

Bayer Corporation

View shared research outputs
Top Co-Authors
Avatar

Joachim Huetter

Bayer Corporation

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge